Mar. 10, 2011: Genzyme CEO Henri Termeer

GREATER BOSTON Greater Boston

A production of  

 

Share Embed Podcasts Play in New Window

Recent Episodes

Supported by:

March 25, 2013: Correction Reform Debate

March 25, 2013: Correction Reform Debate

Greater Boston

March 25, 2013: Dr. Nick Trout

March 25, 2013: Dr. Nick Trout

Greater Boston

March 25, 2013: Newtown in Boston

March 25, 2013: Newtown in Boston

Greater Boston

March 21, 2013: Mayor Tom Menino

March 21, 2013: Mayor Tom Menino

Greater Boston

March 21, 2013: Olin College

March 21, 2013: Olin College

Greater Boston

March 20, 2013: A Raisin in the Sun

March 20, 2013: A Raisin in the Sun

Greater Boston

Schedule

See more
Friday
4/5/13 12:00 PM
WGBH World		 Friday
4/5/13 6:00 PM
WGBH 44		 Friday
4/5/13 7:00 PM
WGBH 2		 Friday
4/5/13 11:30 PM
WGBH World
TBA TBA TBA TBA

Latest Comments


Related Content

About The Show

WGBH's nightly local news program Greater Boston tackles the region's top news stories with original reporting and comprehensive analysis. Host Emily Rooney's discussions with guests from diverse perspectives take viewers beyond the day's headlines.


Watch  Watch: Weekdays at 7:00 pm and 12 midnight on WGBH-2

Podcast Logo  Bookloft Podcast: iTunes | XML

twitter icon  Tweet: @GreaterBoston

facebook  Friend: facebook.com/GreaterBoston

Email Icon  Email: greaterboston@wgbh.org

Beat the Press


On Fridays Greater Boston zooms in on the week's news and newsmakers with Beat The Press, a roundtable discussion scrutinizing and celebrating the media. 


Fridays at 7pm on WGBH 2

Visit the Beat the Press blog >>

1 Guest on Greater Boston


Every Monday this summer, Greater Boston devotes an entire program to a key newsmaker from Keurig co-founder Chris Stevens to rock photographer Rob Shanahan. 

Mondays at 7pm on WGBH 2

Jared Bowen on WGBHArts


The art of enjoying the summer just got a whole lot easier, with reviews, previews and highlights, courtesy of WGBHArts. Greater Boston's arts reporter Jared Bowen leads a group of bloggers, previewing and reviewing the summer's top arts events. 

By this time next month, the French drug company Sanofi-Aventis is expected to complete its $20 billion acquisition of Cambridge biotech giant Genzyme. While Genzyme’s future is now settled, questions remain on what the sale means for Genzyme’s workers and the Massachusetts biotech industry. Genzyme CEO Henri Termeer joins Emily.

Greater Boston updates from WGBH

See a sample »
   

Hong Kong